546 related articles for article (PubMed ID: 29609968)
21. Significant reduction in notification and seroprevalence rates of hepatitis B virus infection among the population of Zhejiang Province, China, aged between 1 and 29years from 2006 to 2014.
Zhou Y; He H; Deng X; Yan R; Tang X; Xie S; Yao J
Vaccine; 2017 Aug; 35(34):4355-4361. PubMed ID: 28687404
[TBL] [Abstract][Full Text] [Related]
22. Prevalence of chronic hepatitis B virus infection after implementation of a hepatitis B vaccination program among children in three provinces in Cambodia.
Mao B; Patel MK; Hennessey K; Duncan RJ; Wannemuehler K; Soeung SC
Vaccine; 2013 Sep; 31(40):4459-64. PubMed ID: 23684825
[TBL] [Abstract][Full Text] [Related]
23. Impact of hepatitis B vaccination among children in Guangdong Province, China.
Xiao J; Zhang J; Wu C; Shao X; Peng G; Peng Z; Ma W; Zhang Y; Zheng H
Int J Infect Dis; 2012 Sep; 16(9):e692-6. PubMed ID: 22795176
[TBL] [Abstract][Full Text] [Related]
24. Improved immunization practices reduce childhood hepatitis B infection in Tonga.
Danielsson N; Fakakovikaetau T; Szegedi E
Vaccine; 2009 Jul; 27(33):4462-7. PubMed ID: 19508908
[TBL] [Abstract][Full Text] [Related]
25. Hepatitis B vaccination in Burkina Faso: prevalence of HBsAg carriage and immune response in children in the western region.
Sanou AM; Ilboudo AK; Meda CZ; Togozia A; Coulibaly A; Cisse A; Sagna T; Kania D; Tarnagda Z
J Infect Dev Ctries; 2018 Nov; 12(11):1002-1008. PubMed ID: 32012131
[TBL] [Abstract][Full Text] [Related]
26. Seroepidemiological study of hepatitis B virus markers in Japan.
Kiyohara T; Ishii K; Mizokami M; Sugiyama M; Wakita T
Vaccine; 2015 Nov; 33(45):6037-42. PubMed ID: 26341564
[TBL] [Abstract][Full Text] [Related]
27. The need for more aggressive follow-up of children born to hepatitis B surface antigen-positive mothers: lessons from the Louisiana Perinatal Hepatitis B Immunization Program.
Kohn MA; Farley TA; Scott C
Pediatr Infect Dis J; 1996 Jun; 15(6):535-40. PubMed ID: 8783352
[TBL] [Abstract][Full Text] [Related]
28. Prevalence of hepatitis B virus infection and carriage after nineteen years of vaccination program in the Western Brazilian Amazon.
Braga WS; Castilho Mda C; Borges FG; Martinho AC; Rodrigues IS; Azevedo EP; Scazufca M; Menezes PR
Rev Soc Bras Med Trop; 2012 Feb; 45(1):13-7. PubMed ID: 22370822
[TBL] [Abstract][Full Text] [Related]
29. Progress Toward Hepatitis B Control and Elimination of Mother-to-Child Transmission of Hepatitis B Virus - Western Pacific Region, 2005-2017.
Woodring J; Pastore R; Brink A; Ishikawa N; Takashima Y; Tohme RA
MMWR Morb Mortal Wkly Rep; 2019 Mar; 68(8):195-200. PubMed ID: 30817746
[TBL] [Abstract][Full Text] [Related]
30. Efficacy of hepatitis B vaccine in the Gambian expanded programme on immunisation.
Fortuin M; Chotard J; Jack AD; Maine NP; Mendy M; Hall AJ; Inskip HM; George MO; Whittle HC
Lancet; 1993 May; 341(8853):1129-31. PubMed ID: 8097813
[TBL] [Abstract][Full Text] [Related]
31. Seroepidemiology of hepatitis B virus infection in children: Ten years of mass vaccination in Taiwan.
Chen HL; Chang MH; Ni YH; Hsu HY; Lee PI; Lee CY; Chen DS
JAMA; 1996 Sep; 276(11):906-8. PubMed ID: 8782640
[TBL] [Abstract][Full Text] [Related]
32. HBV carriage in children born from HIV-seropositive mothers in Senegal: The need of birth-dose HBV vaccination.
Gueye SB; Diop-Ndiaye H; Lo G; Mintsa S; Guindo I; Dia A; Sow-Sall A; Gaye-Diallo A; Mboup S; Touré-Kane C
J Med Virol; 2016 May; 88(5):815-9. PubMed ID: 26488892
[TBL] [Abstract][Full Text] [Related]
33. [Seroepidemiological analysis of hepatitis B among children aged 1-14 in 3 counties of Guangdong province in 2013].
Shao X; Wu C; Wang F; Liang J; Xie X; Zhu Q; Liu J; Hu P; Qiu Q; Liang X; Zheng H
Zhonghua Yu Fang Yi Xue Za Zhi; 2015 Sep; 49(9):777-81. PubMed ID: 26733134
[TBL] [Abstract][Full Text] [Related]
34. HBV immunization and vaccine coverage among hospitalized children in Cameroon, Central African Republic and Senegal: a cross-sectional study.
Bekondi C; Zanchi R; Seck A; Garin B; Giles-Vernick T; Gody JC; Bata P; Pondy A; Tetang SM; Ba M; Ekobo CS; Rousset D; Sire JM; Maylin S; Chartier L; Njouom R; Vray M
BMC Infect Dis; 2015 Jul; 15():267. PubMed ID: 26164361
[TBL] [Abstract][Full Text] [Related]
35. Cost-effectiveness analysis of hepatitis B vaccine booster in children born to HBsAg-positive mothers in rural China.
Wang Y; Shi JF; Wang L; Yan Y; Yao H; Dai M; Chen T; Qu C
Int J Infect Dis; 2019 Jan; 78():130-139. PubMed ID: 30466898
[TBL] [Abstract][Full Text] [Related]
36. The risk factors of transmission after the implementation of the routine immunization among children exposed to HBV infected mothers in a developing area in northwest China.
Li F; Wang Q; Zhang L; Su H; Zhang J; Wang T; Huang D; Wu J; Yan Y; Fan D
Vaccine; 2012 Nov; 30(49):7118-22. PubMed ID: 23022150
[TBL] [Abstract][Full Text] [Related]
37. The long-term efficacy, 13-23 years, of a plasma-derived hepatitis B vaccine in highly endemic areas in China.
Wang F; Shen L; Cui F; Zhang S; Zheng H; Zhang Y; Liang X; Wang F; Bi S
Vaccine; 2015 May; 33(23):2704-9. PubMed ID: 25843269
[TBL] [Abstract][Full Text] [Related]
38. Hepatitis B surface antigen seroprevalence among pre- and post-vaccine cohorts in Cambodia, 2017.
Ork V; Woodring J; Shafiqul Hossain M; Wasley A; Nagashima S; Yamamoto C; Chuon C; Sugiyama A; Ohisa M; Akita T; Ko K; Mao B; Tanaka J
Vaccine; 2019 Aug; 37(35):5059-5066. PubMed ID: 31285088
[TBL] [Abstract][Full Text] [Related]
39. [Assessment of mother-to-child HBV transmission at the prenatal consultation in Vientiane, Laos].
Xaydalasouk K; Keomalaphet S; Latthaphasavang V; Souvong V; Buisson Y
Bull Soc Pathol Exot; 2016 Feb; 109(1):13-9. PubMed ID: 26821371
[TBL] [Abstract][Full Text] [Related]
40. Factors associated with effectiveness of the first dose of hepatitis B vaccine in China: 1992-2005.
Cui F; Li L; Hadler SC; Wang F; Zheng H; Chen Y; Gong X; Hutin YJ; Cairns KL; Liang X; Yang W
Vaccine; 2010 Aug; 28(37):5973-8. PubMed ID: 20637773
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
